Molecular Diagnostics Lab. V. Hoffman-LaRoche, Inc., et al.
Serving as co-lead counsel, Cohen Milstein obtained a $33 million settlement against two large biotechnology companies after more than four years of hard-fought litigation. The class alleged that the two companies improperly exploited and enforced a patent claiming Thermus aquaticus DNA polymerase (“Taq”), an enzyme that has been crucial to discoveries in medical diagnostics and treatment, the study of the human genomes, and criminal forensics. The court granted final approval to the settlement.